Elutia Inc

ELUT

Company Profile

  • Business description

    Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women’s Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

  • Contact

    12510 Prosperity Drive
    Suite 370
    Silver SpringMD20904
    USA

    T: +1 240 247-1170

    https://www.aziyo.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    51

Stocks News & Analysis

stocks

Unconventional wisdom: Should I sell this underperforming ASX share?

Going back to my original thesis to evaluate a position.
stocks

Wildly overvalued ASX stock is skating on thin ice

This company dominates its industry and could be flirting with regulatory intervention.
stocks

Uber flexes its network effect and delivers strong result

Uber’s business is humming along but autonomous vehicles add uncertainty to the longer term outlook.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,079.6022.40-0.25%
CAC 407,709.3274.290.97%
DAX 4024,192.50268.141.12%
Dow JONES (US)43,968.64224.48-0.51%
FTSE 1009,100.7763.54-0.69%
HKSE24,845.78235.85-0.94%
NASDAQ21,242.7073.270.35%
Nikkei 22541,814.26755.111.84%
NZX 50 Index12,844.6342.47-0.33%
S&P 5006,340.005.06-0.08%
S&P/ASX 2008,811.6019.80-0.22%
SSE Composite Index3,636.882.79-0.08%

Market Movers